Transvenous Electrical Cardioversion of Equine Atrial Fibrillation: Patient Factors and Clinical Results in 72 Treatment Episodes
Authors:
- 1 May 2008
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 22 (3) , 609-615
Abstract
Background: Transvenous electrical cardioversion (TVEC) has been developed for treatment of atrial fibrillation (AF) in horses. The relationship among patient variables, treatment response, and outcome in a typical referral population has not been evaluated. Hypothesis: Patient variables such as age, sex, weight, and duration of arrhythmia affect prognosis for response to treatment and the energy level at which cardioversion occurs. Animals: TVEC was applied to 72 episodes of lone AF in 63 client-owned performance horses, with the majority (54) being Standardbred racehorses. Methods: Catheterization of the right atrium (RA) and pulmonary artery (PA) through the jugular vein was used for electrode placement before horses were placed under general anesthesia. Biphasic, truncated exponential shock waves were delivered at incremental energy levels until cardioversion was achieved or a maximum single-energy level of 300 J was reached (cumulative energy 50–1,960 J). A multivariate model was constructed to evaluate influence of patient factors on cardioversion energy. Results: Cardioversion was achieved in 71 of 72 episodes (62 of 63 horses) at a mean energy of 165.43 ± 8.75 J. Cardioversion energy was higher for females than for males, and for interaction terms, weight was negatively related to energy in females and positively related in males. Age was positively related to cardioversion energy in females. No relationship was identified between duration of arrhythmia before treatment and prognosis for response or cardioversion energy. Conclusions and Clinical Importance: TVEC is highly effective in the treatment of lone AF in horses. Although age and sex influence cardioversion energy level, duration of arrhythmia does not.Keywords
This publication has 24 references indexed in Scilit:
- Biomarkers in Acute Cardiac DiseaseJACC, 2006
- Cloning and Sequencing of Equine Cardiac Troponin I and Confirmation of Its Usefulness as a Target Analyte for Commercial Troponin I AnalyzersJournal of Veterinary Diagnostic Investigation, 2005
- How to perform transvenous electrical cardioversion in horses with atrial fibrillationJournal of Veterinary Cardiology, 2005
- Cardiac biochemical markers after cardioversion of atrial fibrillation or atrial flutterAmerican Heart Journal, 2000
- Differential reactivity of cardiac and skeletal muscle from various species in two generations of cardiac troponin-T immunoassaysResearch in Veterinary Science, 1998
- Measurement of cardiac function by transthoracic echocardiography: day to day variability and repeatability in normal Thoroughbred horsesEquine Veterinary Journal, 1998
- Cardiac Troponin I Levels Are Normal or Minimally Elevated After Transthoracic CardioversionJACC, 1997
- Cardiac Troponin I Does Not Increase After CardioversionChest, 1997
- Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurationsThe American Journal of Cardiology, 1995
- TWO‐DIMENSIONAL, REAL‐TIME ECHOCARDIOGRAPHY IN THE HORSEVeterinary Radiology, 1987